High Pointe Capital Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2.11M Sell
4,848
-430
-8% -$180K 1.52% 27
2021
Q4
$2.45M Buy
5,278
+878
+20% +$389K 1.63% 21
2021
Q3
$1.71M Hold
4,400
1.35% 35
2021
Q2
$1.95M Buy
4,400
+1,040
+31% +$454K 1.53% 23
2021
Q1
$1.41M Hold
3,360
1.24% 40
2020
Q4
$1.38M Buy
3,360
+1,480
+79% +$615K 1.31% 40
2020
Q3
$778K Sell
1,880
-40
-2% -$16.1K 0.94% 47
2020
Q2
$744K Buy
+1,920
New +$718K 0.98% 43

Other funds holding HUM

High Pointe Capital Management's HUM Position: Q1 2022 in Review

High Pointe Capital Management reduced its Humana (HUM) stake by 8.1% in Q1 2022, selling an estimated $180K and leaving 4,848 shares worth $2.11M. The position accounts for 1.52% of the portfolio, ranked #27.

High Pointe Capital Management first reported a position in HUM in Q2 2020 and has held it in 8 quarters since. The position peaked at $2.45M in Q4 2021. 915 funds tracked by Wall St. Rank hold HUM as of Q1 2022.

  • High Pointe Capital Management held 4,848 shares of Humana worth $2.11M as of Q1 2022.
  • High Pointe Capital Management sold 430 Humana shares in Q1 2022, an estimated $180K.
  • Humana made up 1.52% of High Pointe Capital Management's portfolio in Q1 2022, its #27 holding.
  • High Pointe Capital Management first reported a position in Humana in Q2 2020 and has held it in 8 quarters since.
  • High Pointe Capital Management's Humana position peaked at $2.45M in Q4 2021.
  • 915 funds tracked by Wall St. Rank held Humana as of Q1 2022.

Based on High Pointe Capital Management's 13F filing for Q1 2022, filed 10 May 2022.